Takeda Archives | Be Korea-savvy
Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

GAITHERSBURG, Md. and OSAKA, Japan, Aug. 7 (Korea Bizwire) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), today announced a partnership for the development, manufacturing and commercialization of NVX‑CoV2373, Novavax’ COVID‑19 vaccine candidate, in Japan. NVX‑CoV2373 is a stable, prefusion [...]

Light Chain Bioscience Successfully Completes Factor VIII Mimetic Bispecific Antibody Discovery for Takeda

Light Chain Bioscience Successfully Completes Factor VIII Mimetic Bispecific Antibody Discovery for Takeda

GENEVA, Switzerland, Feb. 14 (Korea Bizwire) — Light Chain Bioscience, a company developing bispecific antibodies with a pipeline focused in immuno-oncology, announced that it has achieved a milestone and received a payment under its research and collaboration agreement with Takeda Pharmaceutical Company Limited (Takeda). The milestone was achieved upon the successful completion of the discovery [...]